EFDID: 508668EFD: View Filing

Issuer: NexPoint Life Sciences III DST (0002008210) - D/A

Accession: 0002008210-25-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002008210
  • Entity Name:
    NexPoint Life Sciences III DST
  • Entity Type:
    Other
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2023)
  • Address:
    300 CRESCENT COURT
    SUITE 700
    DALLAS, TX 75201
  • Persons:
    Related Persons 5
    N/A NexPoint Real Estate Advisors IV, L.P.
    Executive Officer 
    Sponsor of the Issuer
    Brian Mitts
    Executive Officer 
    Authorized Signatory of the Issuer
    Matt McGraner
    Executive Officer 
    Authorized Signatory of the Issuer
    N/A NREA LS III Manager, LLC
    Executive Officer 
    Manager and Signatory Trustee of the Issuer
    N/A NREA LS III Contributor, LLC
    Executive Officer 
    Contributor of the Issuer
EDGAR: Offering Information
  • Accession Date:
    01/22/2025
  • First Sale Date:
    01/25/2024
  • Offering Amount:
    $30,661,253
  • Amount Sold:
    $9,565,646
  • Amount Remaining:
    $21,095,607
  • Exemptions:
    Section 3(c)(1) , Rule 506(c), Investment Company Act Section 3(c) , Section 3(c)(5)
  • Security Type(s):
    Equity, Pooled Investment Fund
  • Sales Clarification:
    Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AZ, CA, CO, HI, IL, KS, MA, MD, ME, MN, NC, NM, NV, OK, OR, PA, SC, TX, WA, WI
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Aurora Securities 46147 None None WA
Emerson Equity LLC 130032 None None CA, CO, FL, WA
DFPG Investments, LLC 155576 None None CA, OR, PA
Arkadios Capital 282710 None None CA, FL
Realized Financial, Inc. 22333 None None MN, OK, TX
IBN Financial Services, Inc. 42360 None None ME
Great Point Capital LLC 114203 None None CA, IL
Centaurus Financial, Inc. 30833 None None CA, NC
Creativeone Securities, LLC 152974 None None AZ, CA
American Trust Investment Services, Inc. 3001 None None MA, NV, WI
Independent Financial Group, LLC 7717 None None CA, NM
Westpark Capital, Inc. 39914 None None CA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
NexPoint Life Sciences III DST/s/Paul A. RichardsPaul A. RichardsAuthorized Signatory of the Issuer2025-01-22
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jan. 13, 2026 508668: 0002008210-26-000001 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $25,178,789
Remaining: $5,482,464
D/A Aug. 06, 2025 508668: 0002008210-25-000004 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $14,150,789
Remaining: $16,510,464
D/A Apr. 18, 2025 508668: 0002008210-25-000003 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $11,537,013
Remaining: $19,124,240
D/A Jan. 29, 2025 508668: 0002008210-25-000002 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $9,865,646
Remaining: $20,795,607
D/A Jan. 22, 2025 508668: 0002008210-25-000001 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $9,565,646
Remaining: $21,095,607
D/A Dec. 17, 2024 508668: 0002008210-24-000011 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $8,610,539
Remaining: $22,050,714
D/A Nov. 06, 2024 508668: 0002008210-24-000010 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $6,566,766
Remaining: $24,094,487
D/A Oct. 16, 2024 508668: 0002008210-24-000009 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $4,789,837
Remaining: $25,871,416
D/A Sep. 26, 2024 508668: 0002008210-24-000008 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $4,198,753
Remaining: $26,462,500
D/A Aug. 12, 2024 508668: 0002008210-24-000007 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $4,023,753
Remaining: $26,637,500
D/A Jul. 10, 2024 508668: 0002008210-24-000006 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $2,913,131
Remaining: $27,748,122
D/A May. 21, 2024 508668: 0002008210-24-000005 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $1,946,858
Remaining: $28,714,395
D/A Mar. 26, 2024 508668: 0002008210-24-000004 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $1,551,858
Remaining: $29,109,395
D/A Mar. 12, 2024 508668: 0002008210-24-000003 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $517,406
Remaining: $30,143,847
D/A Feb. 21, 2024 508668: 0002008210-24-000002 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $417,406
Remaining: $30,243,847
D Jan. 31, 2024 508668: 0002008210-24-000001 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $148,529
Remaining: $30,512,724